A Tertiary Care Center's Experience with Andexanet Alfa for Reversal of Factor Xa Inhibitor Associated Intracranial Hemorrhage

被引:0
|
作者
Smith, Matthew [1 ,2 ]
Beatty, Julia [3 ]
Keegan, Shaun [3 ,4 ]
Robinson, David [4 ]
Walsh, Kyle [2 ,4 ,5 ]
Garber, Paige [3 ]
机构
[1] Univ Cincinnati, Neurol, Cincinnati, OH USA
[2] Gardner Neurosci Inst, Cincinnati, OH USA
[3] James L Winkle Coll Pharm, Cincinnati, OH USA
[4] Div Neurocrit Care, Cincinnati, OH USA
[5] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P3.9-008
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
    Kreutziger, Janett
    Ulmer, Hanno
    Fries, Dietmar
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (08): : 772 - 774
  • [32] Andexanet for factor Xa inhibitor-associated acute intracerebral hemorrhage
    Leafloor, Cameron
    Green, Robert
    Sharif, Sameer
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2025, 27 (02) : 104 - 106
  • [33] Economic Evaluation of Andexanet Versus Prothrombin Complex Concentrate for Reversal of Factor Xa-Associated Intracranial Hemorrhage
    Micieli, Andrew
    Demchuk, Andrew M.
    Wijeysundera, Harindra C.
    STROKE, 2021, 52 (04) : 1390 - 1397
  • [35] Andexanet alfa for reversal of factor Xa inhibitors: a critical review of the evidence
    Abdulrehman, Jameel
    Eikelboom, John W.
    Siegal, Deborah M.
    FUTURE CARDIOLOGY, 2019, 15 (06) : 395 - 404
  • [36] Outcomes Associated With Andexanet Use in Patients With Factor Xa Inhibitor-Associated Intracranial Hemorrhage: A One-Year Single-Center Analysis
    Concha, M.
    Shomo, E.
    Busey, K., V
    Case, D.
    Brockhurst, A.
    Giovino, A.
    ANNALS OF EMERGENCY MEDICINE, 2019, 74 (04) : S80 - S80
  • [37] Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage Reply
    Shoamanesh, Ashkan
    Sharma, Mukul
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (08): : 773 - 774
  • [39] Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass
    Thalji, Nabil K.
    Patel, Prakash A.
    Camire, Rodney M.
    BLOOD, 2019, 134
  • [40] COST COMPARISON OF ANDEXANET VERSUS PCC FOR DIRECT FACTOR XA INHIBITOR REVERSAL AFTER HEMORRHAGE
    Frontera, Jennier
    Joset, Danielle
    Lalchan, Rebecca
    Ahuja, Tania
    Papadopoulis, John
    CRITICAL CARE MEDICINE, 2019, 47